ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 1286 • 2015 ACR/ARHP Annual Meeting

    Persistent Individual and Neighborhood Poverty Are Independent Risk Factors for Accumulated Lupus Damage

    Laura Trupin1, Stephanie Rush2, Jinoos Yazdany3 and Edward H. Yelin4, 1Medicine/Rheumatology, University of California San Francisco, San Francisco, CA, 2UCSF, SF, CA, 3University of California, San Francisco, San Francisco, CA, 4Medicine/Rheumatology, UC San Francisco, San Francisco, CA

    Title:  Persistent Individual and Neighborhood Poverty Are Independent Risk Factors for Accumulated Lupus Damage Background/Purpose: Previous research in systemic lupus erythematosus (SLE) has shown that…
  • Abstract Number: 1287 • 2015 ACR/ARHP Annual Meeting

    Impact of Participation in Adalimumab Patient Support Program (PSP)  on Clinical Outcomes and Predictors of PSP Utilization Among Patients with Rheumatoid Arthritis

    Filip van Den Bosch1, Siegfried Wassenberg2, Andrew Östör3, Nupun A. Varothai4, Vishvas Garg4 and Jasmina Kalabic4, 1Ghent University Hospital, Ghent, Belgium, 2Fachkrankenhaus, Ratingen, Germany, 3Addenbrooke's Hospital, Cambridge, United Kingdom, 4AbbVie, North Chicago, IL

    Background/Purpose: Adalimumab (ADA) treated rheumatoid arthritis (RA) patients (pts) are offered patient support programs (PSP) to manage their disease. The purpose of this study is…
  • Abstract Number: 1288 • 2015 ACR/ARHP Annual Meeting

    Dual Care Utilization in Patients Enrolled in the Veterans Affairs Rheumatoid Arthritis Registry

    Pascale Schwab1, Harlan Sayles2, Debra Bergman3, Grant W. Cannon4, Kaleb Michaud5, Ted R. Mikuls2 and Jennifer Barton1, 1VA Portland Health Care System, Portland, OR, 2University of Nebraska Medical Center, Omaha, NE, 3Rheumatology, University of Nebraska Medical Center, Omaha, NE, 4Division of Rheumatology, Salt Lake City VA Medical Center and University of Utah, Salt Lake City, UT, 5Rheumatology & Immunology, University of Nebraska Medical Center and National Data Base for Rheumatic Diseases, Omaha, NE

    Background/Purpose:   While use of multiple health care systems may allow rapid access to medical care, the practice results in fragmented and redundant treatments at…
  • Abstract Number: 1289 • 2015 ACR/ARHP Annual Meeting

    Healthcare Utilization Differences According to Sex Among Children and Adults in Medicaid with Incident Lupus Nephritis

    Candace H. Feldman1, Anna R. Broder2, Hongshu Guan3, Anand Kumthekar4, Michail Alevizos5, Jinoos Yazdany6 and Karen H. Costenbader7, 1Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 2Rheumatology-Forchheimer 701N, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, NY, 3Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, MA, 4Medicine, Albert Einstein College of Medicine/Jacobi Medical Center, Bronx, NY, 5Medicine, Albert Einstien College of Medicine/Jacobi Medical Center, Bronx, NY, 6Rheumatology, University of California, San Francisco, San Francisco, CA, 7Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA

    Background/Purpose: Past studies suggest that males with lupus nephritis (LN) may have increased rates of end-stage renal disease (ESRD) and mortality compared to females. Most…
  • Abstract Number: 1290 • 2015 ACR/ARHP Annual Meeting

    Burden of Rheumatoid Arthritis in the US Elderly Population: Comorbidities, Healthcare Resource Utilization, and Cost

    Chieh-I Chen1, Li Wang2, Wenhui Wei3, Huseyin Yuce4 and Kristine Phillips5, 1Regeneron Pharmaceuticals, Inc., Tarrytown, NY, 2Director, Analytic Research, STATinMED Research, Plano, TX, 3Sanofi-Aventis, Bridgewater, NJ, 4New York City College of Technology (CUNY), New York, NJ, 5Rheumatology, University of Michigan, Ann Arbor, MI

    Background/Purpose: Rheumatoid arthritis (RA) is a systemic inflammatory disease resulting in significant healthcare resource utilization (HRCU) and cost. Data on elderly RA patients are generally…
  • Abstract Number: 1291 • 2015 ACR/ARHP Annual Meeting

    The Pediatric Rheumatology Workforce in 2015: A Survey of Pediatric Rheumatologists

    Meredith Riebschleger1, Mara L Becker2, Holly S. Ruch-Ross3, 'Laura Laskosz4, Carrie Radabaugh5, Polly J. Ferguson6, Kenneth N. Schikler7 and Sandy D. Hong8, 1Pediatric Rheumatology & Health Services Research, University of Michigan, Ann Arbor, MI, 2Rheumatology, Children's Mercy Kansas City, Kansas City, MO, 3Independent Research and Evaluation Consultant, Evanston, IL, 4Division of Technical and Medical Services, The American Academy of Pediatrics, Elk Grove Village, IL, 5Department of Education, American Academy of Pediatrics, Elk Grove Village, IL, 6Dept of Pediatrics--Rheum, University of Iowa, Iowa City, IA, 7Pediatrics, University of Louisville, Louisville, KY, 8Pediatrics-Rheumatology, U of Iowa Children's Hosp, Iowa City, IA

    Background/Purpose:  Pediatric Rheumatology (PR) is among the smallest pediatric subspecialties, with only ~300 clinically active board-certified Pediatric Rheumatologists in the US. To better characterize the…
  • Abstract Number: 1292 • 2015 ACR/ARHP Annual Meeting

    What Is the Effect of TNF Inhibitors on Employment Status in Rheumatoid Arthritis Patients and What Are the Predictors of Progression to Unemployment?

    Andrew Chow1, Regan Arendse2, Wojciech Olszynski2, John Kelsall3, Milton F. Baker4, William G Bensen5, Philip Baer6, Anna Jaroszynska7, Denis Choquette8, Suneil Kapur9, Jacqueline Stewart10, Emmanouil Rampakakis11,12, Eliofotisti Psaradellis12, Francois Nantel13, Susan Otawa14, Cathy Tkaczyk14, Allen J Lehman14 and Karina Maslova13, 1University of Toronto/McMaster University, Mississauga, ON, Canada, 2University of Saskatchewan, Saskatoon, SK, Canada, 3Mary Pack Arthritis Centre, Vancouver, Vancouver, BC, Canada, 4VIHA, Victoria, BC, Canada, 5St Joseph's Healthcare Hamilton, Hamilton, ON, Canada, 6Section on Rheumatology, Ontario Medical Association/Journal of the Canadian Rheumatology Association, Toronto, ON, Canada, 7Private Practice, Burlington, ON, Canada, 8Rheumatology Department, Institut de Rhumatologie de Montréal and University of Montreal, Montreal, QC, Canada, 9Rheumatology, University of Ottawa, Ottawa, ON, Canada, 10Penticton Regional Hospital, Penticton, BC, Canada, 11JSS Medical Research, St-Laurent, QC, Canada, 12JSS Medical Research, Montreal, QC, Canada, 13Janssen Inc., Toronto, ON, Canada, 14Medical Affairs, Janssen Inc., Toronto, ON, Canada

    Background/Purpose: Rheumatoid arthritis (RA) is a chronic, progressive inflammatory disease which has been associated with an increased incidence of disability and unemployment over time. The…
  • Abstract Number: 1293 • 2015 ACR/ARHP Annual Meeting

    A Comparison of Prenatal Care  in Mothers with and without JIA: Association with Outcomes

    Debbie Ehrmann Feldman1, Anick Bérard2, Evelyne Vinet3, Ciarán M. Duffy4, Elizabeth Hazel5, Marie-Pierre Sylvestre6, Garbis Meshefedjian7 and Sasha Bernatsky8, 1School of Rehabilitation, Université de Montréal, Montreal, QC, Canada, 2Université de Montréal, Montréal, QC, Canada, 3Divisions of Rheumatology and Clinical Epidemiology, McGill University Health Centre, Montreal, QC, Canada, 4Children's Hospital of Eastern Ontario and University of Ottawa, Ottawa, ON, Canada, 5Rhematology, McGill University Health Centre, Montreal, QC, Canada, 6Université de Montréal, Montreal, QC, Canada, 7Public Health Department of Montreal, Montreal, QC, Canada, 8Rheum/Clin. Epid., McGill MUHC/RVH, Montreal, QC, Canada

    Background/Purpose: Women who had JIA in childhood and adolescence may be at higher risk for adverse neonatal and maternal outcomes. Our objective was to examine…
  • Abstract Number: 1294 • 2015 ACR/ARHP Annual Meeting

    Infection and Screening Costs Related to Tumor Necrosis Factor-Alpha Inhibitor Use

    Elizabeth G. Salt1, Amanda T. Wiggins1, Mary Kay Rayens1, David Mannino2, Huaman Joo Moises3, Allison R. Jones4, Scott A. Merkley5, Philip Schwieterman6 and Leslie J. Crofford7, 1College of Nursing, University of Kentucky, Lexington, KY, 2Colege of Medicine and Public Health, University of Kentucky, Lexington, KY, 3College of Medicine- Infectious Disease, Univesity of Kentucky, Lexington, KY, 4University of Kentucky, Lexington, KY, 5Lexington Clinic, Lexington, KY, 6College of Pharmacy, University of Kentucky, Lexington, KY, 7Medicine, Vanderbilt University, Nashville, TN

    Background/Purpose: Bacterial and fungal infections (e.g., tuberculosis, histoplasmosis) have been associated with the use of TNF-α inhibitors (TNFI). Although screening for specific infections prior to…
  • Abstract Number: 1295 • 2015 ACR/ARHP Annual Meeting

    Online Consultation for Rheumatic Disease Patients Based on Smart System of Disease Management (SSDM) Mobile Tools: A Study of Medical Economics

    Fei Xiao1, Xiangyuan Liu2, Hua Wei3, Zhijun Li4, Yanhong Huang5, Yaohu Jiang6, Huiqiong Zhou7, Jie Shen8, Yuhua Jia1, Li Zhang1, Yuan Liu1, Minjun Wang1 and Fengchun Zhang9, 1Gothic Internet Technology Corporation, Shanghai, China, 2Department of Rheumatology and Immunology, Peking University Third hospital, Bei jing, China, 3No 98,Nantong West Rd,Yangzhou, Northern Jiangsu People's Hospital, Yangzhou, China, 4The First Affiliated Hospital of Bengbu Medical College, Bengbu, China, 5Beijing Jishuitan Hospital, Beijing, China, 6Renji Hospital Shanghai Jiaotong University School of Medicine, Shanghai, China, 7The First Affiliated Hospital of PLA General Hospital, Beijing, China, 8University of Rochester, Rochester, NY, 9Department of Rheumatology, Peking Union Medical college Hosptial, Beijing, China

    Background/Purpose: China has no primary medical care and referral system. Patients can choose any hospitals or any doctors they like to seek medical care. As…
  • Abstract Number: 1296 • 2015 ACR/ARHP Annual Meeting

    Evaluating Inter-Rater Reliability in Joint Count to Promote Quality and Trust in a Clinical Arthritis Care Team

    Diane Tin1, Lorna J. Bain1, J Carter Thorne2, Meen Jae Lee2,3, Lois Derrick1,4, E Jean Painter1, Annabelle Estaban1, Nooshin Samadi2, Sue Charette1, Sherry Hartnett1, Carolyn Bornstein1, Edward Ng2 and Michael Aubrey2, 1The Arthritis Program, Southlake Regional Health Centre, Newmarket, ON, Canada, 2Southlake Regional Health Centre, Newmarket, ON, Canada, 3Pharmacology, McGill University, Montreal, QC, Canada, 4The Arthritis Society, Toronto, ON, Canada

    Background/Purpose: Joint count assessment is essential for the diagnosis and ongoing evaluation of Rheumatoid Arthritis (RA) disease activity. In our team based, interprofessional approach to…
  • Abstract Number: 1297 • 2015 ACR/ARHP Annual Meeting

    Improving the Medication Prior Authorization Process in a University Based Rheumatology Practice

    Jessica King1, Megan E. B. Clowse2, Stephanie Puryear3 and Steven Collins3, 1Rheumatology, Duke University Health System, Hillsborough, NC, 2Rheumatology & Immunology, Duke University, Durham, NC, 3Rheumatology, DUHS, Durham, NC

    Background/Purpose:   The vast majority of medications prescribed to treat rheumatologic conditions now require insurance prior authorization (PA) before the medication will be paid for…
  • Abstract Number: 1298 • 2015 ACR/ARHP Annual Meeting

    Advocating for Rheumatoid Arthritis and Cardiovascular Health (ARCH): A Collaborative and Systems-Based Approach to Improve Access to Care

    Barbara Goldstein and JoAnn Zell, Medicine, National Jewish Health, Denver, CO

    Background/Purpose: Patients with rheumatoid arthritis (RA) have an increased risk of cardiovascular disease (CVD) as compared to the general population. The European League Against Rheumatism…
  • Abstract Number: 1299 • 2015 ACR/ARHP Annual Meeting

    Can Bone Marrow Lesions be Scored More Reliably and Responsively in Knee Osteoarthritis Using a Web-Based Overlay System (KIMRISS) Than By Standard MRI Osteoarthritis Knee Scoring (MOAKS)?  Data from the Osteoarthritis Initiative and a Prospective Trial of Adaluminab Therapy

    Jacob Jaremko1, Mark Buller2, Dean Jeffery2, David McDougall3, Benjamin Smith2, Robert G Lambert1 and Walter Maksymowych4, 1Radiology, Radiology, University of Alberta, Edmonton, AB, Canada, 2Radiology & Diagnostic Imaging, University of Alberta, Edmonton, AB, Canada, 3Radiology, University of Alberta, Edmonton, AB, Canada, 4Medicine, University of Alberta, Edmonton, AB, Canada

    Background/Purpose: Bone marrow lesions (BML) relate to pain and prognosis in knee osteoarthritis.  The Knee Inflammation MRI Scoring System (KIMRISS) offers simple template-assisted binary BML…
  • Abstract Number: 1300 • 2015 ACR/ARHP Annual Meeting

    Comparison Between Semiquantitative and Quantitative Methods for the Assessment of Knee Synovitis Using Non-Enhanced and Gadolinium-Enhanced MRI

    Michel D. Crema1, Frank Roemer2, Ling Li3, Laura B. Rosen4, Amanda Dudley5, Robert Alexander6 and Ali Guermazi7, 1Department of Radiology, Boston University School of Medicine, Boston, MA, 2Radiology, Boston University School of Medicine, Boston, MA, 3Dana-Farber Cancer Institute, Boston, MA, 4AstraZeneca Neuroscience Innovative Medicines, Cambridge, MA, 5AstraZeneca Neuroscience Innovative Medicines, Cambridge, United Kingdom, 6Pfizer Neuroscience, Cambridge, MA, 7Boston University School of Medicine, Boston, MA

    Background/Purpose:   There is evidence that the presence of synovitis in knee osteoarthritis (OA) is clinically relevant since it is associated with pain and structural…
  • « Previous Page
  • 1
  • …
  • 1773
  • 1774
  • 1775
  • 1776
  • 1777
  • …
  • 2425
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology